Glenmark received manufacturing and marketing approval from India's drug regulator for Nitric Oxide Nasal Spray as part of accelerated approval process for the treatment of adult patients with COVID-19 who have high risk of progression of the disease. The double-blind, parallel arm, multicenter study, conducted in 306 patients evaluated the efficacy and safety of Nitric Oxide Nasal Spray versus normal …
Glenmark Pharmaceuticals Ltd, in collaboration with Canadian pharmaceutical company SaNOtize, announced the launch of a nitric oxide nasal spray called ‘FabiSpray’ in India on Wednesday. The company had earlier received manufacturing and marketing approval for FabiSpray from the Drugs Controller General of India as part of the accelerated approval process. Robert Crockart, chief commercial officer at Glenmark, said on the …
Drug firm Glenmark Pharmaceuticals on Monday said it has signed an agreement with Canadia's biotech firm SaNOtize Research and Development Corp to commercialise its Nitric Oxide Nasal Spray for Covid-19 treatment in India and other Asian markets. Glenmark Pharmaceuticals and SaNOtize Research and Development Corp announced an exclusive long term strategic partnership to manufacture, market and distribute its breakthrough Nitric …
SaNOtize, a Canada-based pharmaceutical firm, has sought emergency approval from the United Kingdom and Canada for the use of its nitric oxide nasal spray. The company claims that the nasal spray can be used as an effective treatment for Covid-19 as it kills 99.9 per cent of the virus. The trial in the UK has shown that it dramatically reduces …
